Regulation of catechol-O-methyltransferase expression in human myometrial cells

Obstetrics and Gynecology

Volumn 108, Issue 6, 2006, Pages 1439-1447

  Wentz, Melissa J ^b   Jamaluddin, Mohammad ^b   Garfield, Robert E ^b   Al Hendy, Ayman ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 HYDROXYESTRADIOL; CATECHOL METHYLTRANSFERASE; ESTROGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTACYSTIN; LUCIFERASE; PROGESTERONE; PROTEASOME INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME REGULATION; ESTROGEN RESPONSIVE ELEMENT; HORMONE SENSITIVITY; HUMAN; HUMAN CELL; MYOMETRIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSACTIVATION; WESTERN BLOTTING;

ACETYLCYSTEINE; BLOTTING, WESTERN; CATECHOL O-METHYLTRANSFERASE; CELLS, CULTURED; DOWN-REGULATION; ESTROGENS; FEMALE; GENES, REPORTER; HUMANS; HYDROXYESTRONES; LUCIFERASES; MYOMETRIUM; PROGESTERONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANS-ACTIVATION (GENETICS); TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 33845460601     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.AOG.0000243775.73788.11     Document Type: Article

References (28)

1. Axelrod J, Tomchick R. Enzymatic O-methylation of epinephrine and other catechols. J Biol Chem 1958;233:702-5.
2. Creveling CR. The role of catechol-O-methyltransferase in the inactivation of catecholestrogen. Cell Mol Neurobiol 2003;23:289-91.
3. Vandewalle B, Lefebvre J. Opposite effects of estrogen and catecholestrogen on hormone-sensitive breast cancer cell growth and differentiation. Mol Cell Endocrinol 1989;61:239-46.
4. Bradlow LH, Telang NT, Sepkovic DW. Osborne 2-Hydroxyesterone: the "good" estrogen. J Endocrinol 1996;150:S259-65.
5. Al-Hendy A, Salama SA. Catechol-O-methyltransferase polymorphism is associated with increased uterine leiomyoma risk in different ethnic groups. J Soc Gynecol Investig 2006;13:136-44.
6. Banerjee SN, Sengupta K, Banerjee S, Saxena NK, Banerjee SK. 2-Methoxyestradiol exhibits a biphasic effect on VEGF-A in tumor cells and upregulation is mediated through ER-alpha: a possible signaling pathway associated with the impact of 2-ME2 on proliferative cells. Neoplasia 2003;5:417-26.
7. Lippert C, Seeger H, Mueck AO. The effect of endogenous estradiol metabolites on the proliferation of human breast cancer cells. Life Sci 2003;72:877-83.
8. Liu ZJ, Zhu BT. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells. J Steroid Biochem Mol Biol 2004;88:265-75.
9. Sutherland TE, Schuliga M, Harris T, Eckhardt BL, Anderson RL, Quan L, et al. 2-methoxyestradiol is an estrogen receptor agonist that supports tumor growth in murine xenograft models of breast cancer. Clin Cancer Res 2005;11:1722-32.
10. Castren O, Saarikoski S. The simultaneous function of catechol-O-methyltransferase and monoamine oxidase in human placenta. Acta Obstet Gynecol Scand 1974;53:41-7.
11. Barnea ER, MacLusky NJ, DeCherney AH, Naftolin F. Catechol-o-methyl transferase activity in the human term placenta. Am J Perinatol 1988;5:121-7.
12. Casey ML, MacDonald PC. Characterization of catechol-O-methyltransferase activity in human uterine decidua vera tissue. Am J Obstet Gynecol 1983;145:453-7.
13. Briggs MH, Briggs M. Hormonal influences on erythrocyte catechol-O-methyl transferase activity in humans. Experientia 1973;29:278-80.
14. Parvez H, Parvez S, Raza-Bukhari A. Decreased phenylethanolamine-N- methyltransferase and catechol-O-methyltransferase activity in rabbit adrenal glands during pregnancy. Br J Pharmacol 1976;57:413-6.
15. Inoue K, Creveling CR. Induction of catechol-O-methyltransferase in the luminal epithelium of rat uterus by progesterone. J Histochem Cytochem 1991;39:823-8.
16. Xie T, Ho SL, Ramsden D. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Mol Pharmacol 1999;56:31-8.
17. Rauk PN, Surti U, Roberts JM, Michalopoulos G. Mitogenic effect of basic fibroblast growth factor and estradiol on cultured human myometrial and leiomyoma cells. Am J Obstet Gynecol 1995;173:571-7.
18. Al-Hendy A, Lee EJ, Wang HQ, Copland JA. Gene therapy of uterine leiomyomas: adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice. Am J Obstet Gynecol 2004;191:1621-31.
19. Soloff MS, Jeng YJ, Ilies M, Soloff SL, Izban MG, Wood TG, et al. Immortalization and characterization of human myometrial cells from term-pregnant patients using a telomerase expression vector. Mol Hum Reprod 2004;10:685-95.
20. Lee EJ, Duan WR, Jakacka M, Gehm BD, Jameson JL. Dominant negative ER induces apoptosis in GH(4) pituitary lactotrope cells and inhibits tumor growth in nude mice. Endocrinology 2001;142:3756-63.
21. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
22. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. New York (NY): Cold Springs Harbor Laboratory Press; 1989.
23. Gelbke HP, Bottger M, Knuppen R. Excretion of 2-hydroxyestrone in urine throughout human pregnancies. J Clin Endocrinol Metab 1975;41:744-50.
24. Hobkirk R, Nilsen M. Observations on the occurrence of six estrogen fractions in human pregnancy urine. I. Normal pregnancy. J Clin Endocrinol Metab 1962;22:134-41.
25. Hobkirk R, Nilsen M. 2-methoxyestrone as an estrogen metabolite in the human subject. J Clin Endocrinol Metab 1963;23:274-8.
26. Tempfer CB, Schneeberger C, Huber JC. Applications of polymorphisms and pharmacogenomics in obstetrics and gynecology. Pharmacogenomics 2004;5:57-65.
27. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996;6:243-50.
28. Branum AM, Schoendorf KC. Changing patterns of low birthweight and preterm birth in the United States, 1981-98. Paediatr Perinat Epidemiol 2002;16:8-15.